Bryan, Garnier & Co's News

Bone Therapeutics: H1 newsflow delivered on time is a good sign when we look towards H2

BUY, Fair Value EUR26 (+37%)
News published on
September Wednesday 23, 2015


For more information, please contact marketing@bryangarnier.com